Glooko and Innovation Zed Team Up for Digital Health Innovation
Glooko, Inc., a prominent player in the digital health sector, has joined forces with Innovation Zed, a leader in developing connected devices for drug delivery. This partnership aims to transform the way injectable therapies are managed, providing digital companion applications that harness the power of Innovation Zed's advanced DOSE platform technology.
Understanding the Challenges Faced in Injectable Therapies
Injectable therapies play a critical role in managing various chronic diseases. However, they also present numerous challenges that can affect patient adherence and safety. Issues such as complex dosing schedules, fears regarding injections, and inconsistencies in injection techniques can hinder patient engagement. Moreover, inadequate storage practices can diminish medication effectiveness, while insufficient data collection hampers the monitoring of patient progress.
Digital Solutions as a Pathway to Improved Care
This strategic collaboration aims to tackle these challenges head-on by offering a comprehensive digital solution that assists both patients and healthcare providers in optimizing the use of injectable therapies. By providing real-time access to data and resources, Glooko and Innovation Zed are setting the stage for significant improvements in treatment efficacy and patient experience.
Innovative Technology Integration: A Comprehensive Approach
The partnership plans to integrate digital systems with hardware solutions that work together seamlessly. Through the innovative platform that Glooko has developed, currently used by thousands of diabetes clinics around the globe, it will facilitate the collection and analysis of crucial information regarding injectable therapies. This integration will pave the way for enhanced support for both healthcare professionals and patients.
Key Advantages of the Digital Companion Apps
The forthcoming digital companion apps will offer several key benefits, including:
- Boosted Adherence: The applications will ensure accurate tracking and monitoring of dosing regimens, supporting better compliance and optimized therapy outcomes.
- Heightened Safety: The system will provide guidance on maintaining proper storage conditions and offer educational materials on safe injection practices.
- Empowered Patients: Patients will receive support and constructive feedback on their injection techniques, enhancing their confidence in managing their health.
- Streamlined Data Management: The platform will facilitate real-time data capture and connectivity for a diverse array of injectable medications, assisting healthcare providers with valuable insights.
Expanding Horizons for Access and Patient Data
The collaboration leverages Glooko's expansive reach within the healthcare ecosystem, providing critical access to key markets worldwide. This presents a unique opportunity for the pharmaceutical industry to obtain real-world data in real time, leading to a more profound understanding of patient behaviors and treatment responses.
Leadership Insights on the Partnership
According to Mike Alvarez, the Chief Executive Officer of Glooko, the decision to partner with Innovation Zed is sparked by the potential to significantly enhance the digital support systems available to patients and their healthcare providers. He emphasized the importance of this collaboration in fostering improved outcomes and enriching the patient experience.
Dr. Dean Minnock, Chief Executive Officer of Innovation Zed, expressed enthusiasm about the partnership, noting that integrating their cutting-edge drug delivery solutions with Glooko's platform marks a critical advancement in managing injectable therapies.
About the Companies
Glooko is committed to enhancing the health outcomes of individuals with chronic conditions using personalized, connected care solutions. Their technology is used globally in over thirty countries and at thousands of clinical locations, impacting millions of lives.
Innovation Zed focuses on creating user-friendly connected devices that improve the delivery and management of injectable therapies. Their mission aligns perfectly with Glooko’s objectives, working synergistically to boost treatment outcomes.
Frequently Asked Questions
What is the main goal of Glooko and Innovation Zed's partnership?
The partnership aims to develop digital companion apps that optimize the management of injectable therapies while providing crucial patient support.
How will these digital companion apps enhance patient care?
They will improve medication adherence, provide safety guidelines, and empower patients to manage their health effectively.
What challenges are associated with injectable therapies?
Patients often face issues like complex dosing, injection fears, and improper storage practices that may affect medication efficacy.
In which regions will the partnership expand access to injectable therapies?
The partnership will enhance accessibility to injectable therapies in various key markets around the globe.
What type of data will the digital solution capture?
The digital solution will capture real-time data related to dosing, administration techniques, and patient progress, benefiting both patients and providers.
